- Home
- »
- Medical Devices
- »
-
Wound Sealants Market Size & Share Report, 2026-2033GVR Report cover
Wound Sealants Market (2026 - 2033)
Size, Share & Trends Analysis Report By Sealants (Non-synthetic, Collagen Based, Synthetic), By Wound Type (Acute Wounds, Chronic Wounds), By End Use, By Distribution Channel, By Region, And Segment Forecasts
Market Size, 2025
$584.9MMarket Estimate, 2026
$619.0MMarket Forecast, 2033
$880.2MCAGR, 2026–2033
5.2%Wound Sealants Market Size & Trends
The global wound sealants market size was valued at USD 584.9 million in 2025 and is projected to grow from USD 619.0 million in 2026 to USD 880.2 million by 2033, at a CAGR of 5.2% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.3% in 2025. The market's growth is attributed to the rising global volume of surgical procedures, fueled by an aging population and the increasing prevalence of chronic conditions such as diabetes and cardiovascular diseases.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,Download Free Sample Report
Key Market Trends & Insights
- By sealants: Non-synthetic segment led the market with the largest revenue share of 45.3% in 2025.
- By wound type: Acute wounds segment led the market with the largest revenue share of 71.0% in 2025.
- By end use: Acute care hospital segment led the market with the largest revenue share of 36.9% in 2025.
- By distribution channel: Institutional sales segment led the market with the largest revenue share of 81.5% in 2025.
Regional Highlights
- Largest regional market: North America (40.3% revenue share, 2025)
- By country: The U.S. held the largest market share in 2025.
Market Size & Forecast
- Market size in 2025: USD 584.9 Million
- Estimated market size in 2026: USD 619.0 Million
- Projected market size by 2033: USD 880.2 Million
- CAGR (2026-2033): 5.2%
Prism AI by Grand View Research Free to tryAsk a question about the wound sealants marketTry asking✓Every figure cited from GVR research Prefer the report? Download free sample →
The growing demand for minimally invasive surgeries, which require efficient and reliable wound closure methods, further boosts the adoption of sealants. In addition, advancements in biomaterials and synthetic formulations are enhancing wound sealants' effectiveness, safety, and usability, making them a preferred choice in traditional and modern surgical practices.
To learn more about this report,Download Free Sample Report
The rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is anticipated to propel the market growth in the coming years. According to the article published by MDPI, in March 2025, diabetic foot is one of the most serious and challenging complications of diabetes, closely linked to high rates of lower limb amputation, as well as increased illness and mortality. Each year, around 18.6 million people globally are affected by diabetic foot ulcers, which are the leading cause of approximately 80% of diabetes-related lower limb amputations. It is estimated that up to 25% of individuals with diabetes are at risk of developing diabetic foot, and between 19% and 34% may experience foot ulcers at some point in their lifetime. Moreover, according to a study published by the American Medical Association in November 2023, around 33.33% of individuals with diabetes develop a foot ulcer during their lifetime. Diabetic foot ulcers impact about 1.6 million individuals in the U.S. each year. These factors are expected to drive the demand for wound sealants over the forecast period.
The growing number of surgical procedures, including cosmetic, orthopedic, and gynecologic, is anticipated to boost the market growth in the coming years. Wound sealants are widely used in various surgical procedures.
Number of worldwide surgical procedures performed by plastic surgeons
Rank
Surgical Procedure
Total Procedures (2023)
% of Total Surgical Procedures
Total Procedures (2022)
Total Procedures (2019)
% Change 2023 vs. 2022
% Change 2023 vs. 2019
1
Liposuction
2,237,966
14.2%
2,303,929
1,704,786
-2.9%
31.3%
2
Breast Augmentation
1,892,777
12.0%
2,174,616
1,795,551
-13.0%
5.4%
3
Eyelid Surgery
1,746,946
11.0%
1,409,103
1,259,839
24.0%
38.7%
4
Abdominoplasty
1,153,539
7.3%
1,180,623
924,031
-2.3%
24.8%
5
Rhinoplasty
1,148,559
7.3%
944,468
821,890
21.6%
39.7%
6
Breast Lift
903,266
5.7%
955,026
741,284
-5.4%
21.9%
7
Lip Enhancement/Perioral Procedure
901,991
5.7%
699,264
N/A
29.0%
N/A
8
Buttock Augmentation
771,333
4.9%
820,762
479,451
-6.0%
60.9%
9
Fat Grafting - Face
741,061
4.7%
648,894
598,823
14.2%
23.8%
10
Breast Reduction
686,125
4.3%
632,860
600,219
8.4%
14.3%
11
Face Lift
646,482
4.1%
541,491
448,485
19.4%
44.1%
12
Neck Lift
452,639
2.9%
400,593
260,747
13.0%
73.6%
13
Brow Lift
386,427
2.4%
352,324
270,917
9.7%
42.6%
14
Gynecomastia
352,302
2.2%
305,340
273,344
15.4%
28.9%
15
Breast Implant Removal
335,939
2.1%
320,765
229,680
4.7%
46.3%
16
Ear Surgery
327,990
2.1%
303,906
288,905
7.9%
13.5%
17
Upper Arm Lift
244,977
1.5%
204,011
168,289
20.1%
45.6%
18
Labiaplasty
189,058
1.2%
194,086
164,667
-2.6%
14.8%
19
Facial Bone Contouring
153,749
1.0%
138,115
108,536
11.3%
41.7%
20
Thigh Lift
146,264
0.9%
113,746
93,334
28.6%
56.7%
21
Lower Body Lift
128,998
0.8%
123,123
75,895
4.8%
70.0%
22
Buttock Lift
110,167
0.7%
95,174
54,894
15.8%
100.7%
23
Vaginal Rejuvenation
84,495
0.5%
70,645
N/A
19.6%
N/A
24
Upper Body Lift
70,306
0.4%
54,120
N/A
29.9%
N/A
TOTAL SURGICAL PROCEDURES
15,813,353
-
14,986,982
11,363,569
5.5%
39.2%
Source: International Society of Aesthetic Plastic Surgery, Grand View Research
Ongoing innovation in sealant technology, with the development of improved biomaterials, delivery methods, and functionalities, is expanding its applications and driving market growth. For instance, in November 2023, Ethicon, a Johnson & Johnson MedTech company, announced the approval of ETHIZIA. This adjunctive hemostat solution has been clinically proven to achieve sustained hemostasis in challenging bleeding scenarios. Utilizing unique synthetic polymer technology, the ETHIZIA Hemostatic Sealing Patch is the first and only hemostatic matrix designed to provide equally effective hemostatic action on both sides. Furthermore, the trend toward minimally invasive and robotic surgeries has strengthened the need for sealants, as these procedures require precision and controlled closure without excessive tissue manipulation.
Moreover, increasing awareness among healthcare professionals and patients about the advantages of advanced wound care products, including wound sealants, is driving their adoption and supporting market growth. This awareness is being fueled by educational campaigns, clinical evidence showcasing their effectiveness, and a strong focus on achieving better patient outcomes.
Market Dynamics
The increasing number of surgical procedures, traumatic injuries, and chronic wounds globally drives the wound sealants market. Wound sealants are widely used to control bleeding, close surgical incisions, prevent fluid leakage, and promote faster wound healing, making them an important component of modern wound management. The growing preference for minimally invasive and advanced surgical procedures is further driving the adoption of wound sealants, as they improve surgical outcomes and reduce complications. In addition, rising awareness among healthcare professionals regarding effective wound closure techniques, increasing healthcare expenditure, and the growing demand for products that minimize infection risk and shorten hospital stays are contributing to market growth. Continuous advancements in sealant technologies, including synthetic, biological, and combination-based sealants, along with the expanding aging population, which is more susceptible to surgical interventions and chronic wounds, are further strengthening global demand for wound sealants.
The increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, obesity, cancer, and chronic kidney disease is a key driver of growth in the global wound sealants market. Patients suffering from these conditions often experience impaired wound healing and are more likely to undergo surgical procedures, creating a greater need for effective wound closure and bleeding management solutions. Wound sealants help reduce fluid leakage, control bleeding, minimize the risk of infection, and support faster healing in both surgical and chronic wound settings. As the global burden of chronic diseases continues to rise, the number of patients requiring surgeries and advanced wound care interventions is increasing, thereby driving demand for wound sealants across hospitals, ambulatory surgical centers, and specialty clinics.
For instance, in April 2025, the International Diabetes Federation reported that approximately 589 million adults worldwide are living with diabetes, and this number is projected to increase to 853 million by 2050. The growing burden of diabetes is expected to increase the incidence of diabetic foot ulcers and other chronic wounds, thereby driving demand for biomaterial wound dressings.
Advanced wound sealants, including biologic, synthetic, and combination-based sealants, are often more expensive than traditional wound closure methods such as sutures, staples, and adhesive strips. The high costs are primarily associated with complex manufacturing processes, specialized raw materials, extensive clinical testing, and strict regulatory compliance requirements. As a result, healthcare providers, particularly in cost-sensitive and developing markets, limit the use of advanced wound sealants due to budget constraints. In addition, limited reimbursement coverage in certain regions can further restrict product adoption. These cost-related challenges slow the widespread use of advanced wound sealants, particularly in smaller healthcare facilities and emerging economies, thereby restraining overall market growth.
Rising cases of chronic diseases, trauma injuries, cardiovascular disorders, cancer, and age-related conditions are leading to a higher volume of surgeries across hospitals and ambulatory surgical centers. Wound sealants are widely used during and after surgical procedures to control bleeding, prevent fluid leakage, reinforce tissue closure, and promote faster healing.
Compared to conventional wound closure methods, sealants can help reduce complications, shorten recovery times, and improve surgical outcomes. As healthcare systems continue to expand and access to surgical care improves, the demand for effective wound management solutions is expected to increase. This growing surgical volume is creating substantial opportunities for manufacturers to expand the adoption of advanced wound sealant products across a wide range of surgical specialties.
Market Concentration & Characteristics
The wound sealants industry is moderately innovative, with companies focusing on improving the effectiveness of their products. There is a growing trend to use advanced ingredients that help wounds heal faster, prevent infections, and make the healing process more comfortable for patients. In addition, these innovative products are also receiving increasing support from regulatory authorities.
Regulations play a significant role in shaping the market. Regulatory bodies like the FDA ensure that wound care products, including wound sealant products, meet high safety and quality standards before they reach consumers. Manufacturers must follow strict testing and approval processes, which can increase development costs and time, but ensure the safety and reliability of these products.
To learn more about this report,Download Free Sample Report
The wound sealant market is currently experiencing moderate merger and acquisition (M&A) activity, driven by several strategic objectives. Established players are acquiring smaller companies to expand their product portfolios, gain access to innovative technologies, and strengthen their market presence in specific geographies. This consolidation trend allows larger companies to enhance their competitive advantage and capitalize on the growing demand for advanced wound closure solutions in various surgical and wound care applications. For instance, in February 2023, Advanced Medical Solutions Group plc announced the acquisition of Connexicon Medical Limited. Connexicon specializes in tissue adhesive technologies, a strategic addition to bolster AMS’s product portfolio in advanced wound care and surgical adhesives. By integrating Connexicon's tissue adhesive technologies, AMS can expand its portfolio with innovative solutions for wound closure.
Product substitutes for wound sealants include traditional wound closure methods such as sutures, staples, adhesive strips, and surgical tapes. These alternatives are often preferred in certain procedures due to their lower cost, ease of use, or familiarity among surgeons. In addition, newer technologies like hemostatic agents, tissue glues, and advanced wound dressings also serve as substitutes depending on the clinical need.
End user concentration in the wound sealants industry is relatively high, with hospitals, ambulatory surgical centers (ASCs), and specialty clinics accounting for most product usage. These institutions conduct many surgical procedures, where wound sealants are frequently used to control bleeding, seal tissues, and improve surgical outcomes. Larger hospitals and surgical centers tend to establish long-term contracts with manufacturers or distributors, leading to bulk purchasing and more predictable demand patterns.
Analyst Perspective
The wound sealants market is experiencing steady growth, driven by the rising volume of surgical procedures, the increasing prevalence of chronic and acute wounds, and the growing demand for advanced wound closure solutions that reduce healing time and minimize complications. Healthcare providers are increasingly adopting wound sealants as alternatives or adjuncts to traditional sutures and staples due to their ability to achieve effective hemostasis, reduce infection risk, and improve patient outcomes. Technological advancements in synthetic and biologically derived sealants, coupled with the expansion of minimally invasive surgeries, are further supporting market expansion. In addition, the growing emphasis on postoperative care, faster patient recovery, and reduced hospital stays is encouraging the adoption of innovative wound management products, positioning wound sealants as a critical component of modern surgical and wound care practice.
Sealants Insights
Based on sealants, the non-synthetic segment led the market with the largest revenue share of 45.3% in 2025, and collagen-based sealants are expected to grow at the fastest CAGR over the forecast period. This growth can be attributed to these sealants, which facilitate hemostasis and tissue bonding with minimal immune response, making them ideal for sensitive procedures, such as cardiovascular and neurological surgeries. Their natural degradability within the body lowers the risk of postoperative complications and removes the need for removal.
The collagen-based segment is expected to witness the fastest growth over the forecast period. These sealants utilize the natural properties of collagen, a critical protein in the body that plays a significant role in tissue repair and regeneration. By forming a robust adhesive bond, collagen-based sealants not only effectively seal wounds but also create an optimal environment for cellular infiltration and tissue integration, which are among the major factors contributing to the segment's growth.
Wound Type
Based on wound type, the acute wounds segment led the market with the largest revenue share of 71.0% in 2025. This growth can be attributed to the high volume of surgical procedures and traumatic injuries requiring immediate and effective wound management. Surgeries-ranging from cardiovascular and orthopedic to general and emergency procedures-often involve tissue incisions or bleeding that demand reliable sealing solutions to promote rapid healing and prevent complications. Additionally, trauma-related injuries, such as lacerations or burns, frequently occur in emergency settings where wound sealants are favored for their quick application and hemostatic properties.
End Use Insights
Based on end use, the acute care hospital segment led the market with the largest revenue share of 36.9% in 2025. This can be attributed to their central role in performing a wide range of high-risk and high-volume surgical procedures that require effective wound closure solutions. These hospitals handle complex surgeries, including cardiovascular, neurological, trauma, and transplant operations, where wound sealants are essential for controlling bleeding, sealing tissues, and reducing postoperative complications. With access to advanced medical technologies, trained surgical staff, and higher patient inflow, acute care hospitals are the largest consumers of wound sealants.
However, the home healthcare segment is projected to witness the fastest growth rate over the forecast period. This is due to the growing aging population, rising prevalence of chronic wounds, and increasing demand for cost-effective, at-home medical care. As more patients manage post-surgical recovery, diabetic ulcers, and pressure injuries outside of hospital settings, wound sealants offer a convenient, effective, and minimally invasive solution for wound closure and healing.
Distribution Channel Insights
Based on distribution channel, the institutional sales segment led the market with the largest revenue share of 81.5% in 2025. This is because it caters directly to high-volume end users such as hospitals, ambulatory surgical centers, and specialized clinics, where most surgical procedures are performed. These institutions require a consistent supply of wound sealants for various surgical and emergency interventions, often purchasing in bulk through contracts or tenders. Manufacturers and distributors prioritize this segment due to its predictable demand, larger order sizes, and long-term procurement relationships.
To learn more about this report,Download Free Sample Report
However, the retail sales segment is projected to witness the fastest growth rate over the forecast period. This is due to the increasing consumer preference for over-the-counter (OTC) wound care solutions and the rising self-care trend. With the availability of wound sealants in pharmacies, supermarkets, and online platforms, consumers now have easy access to these products for managing minor injuries, cuts, and abrasions at home.
Regional Insights
North America dominated the wound sealants market with the largest revenue share of 40.3% in 2025. The rapid adoption of advanced equipment in the U.S. has allowed the region to account for a larger market share. The presence of leading manufacturers and the quick adoption of advanced products are projected to further boost the region’s growth. The region continuously develops cost-efficient and advanced products for the patients to capture a huge market share. In addition, the rising prevalence of chronic diseases and the growing number of surgeries in the region are factors responsible for the regional market growth.
To learn more about this report,Download Free Sample Report
U.S. Wound Sealants Market Trends
The wound sealants market in the U.S. held the largest share in the North America region in 2025. The U.S. wound sealants market is experiencing growth, driven by combination of rising surgical volumes, increasing demand for minimally invasive procedures, and the growing aging population prone to chronic wounds and comorbidities. Technological advancements in synthetic and bio-based sealants, along with improved product efficacy and ease of use, are also contributing to wider adoption in hospitals, ambulatory surgical centers, and even home care settings.
Europe Wound Sealants Market Trends
Europe wound sealants market is growing with significant growth rate over the forecast period, owing to factors such as high disposable income, presence of a well-established healthcare infrastructure, and the availability of skilled professionals. Moreover, the presence of favorable reimbursement coverage has increased the adoption of surgical procedures. In addition, the increasing geriatric population and rising cases of chronic diseases are also anticipated to drive the market.
The UK wound sealants market is witnessing steady growth, primarily fueled by an aging population, a rising burden of chronic illnesses such as diabetes, and an increasing number of chronic wound cases. According to a March 2024 report by Diabetes UK (The British Diabetic Association), over five million people in the UK are currently living with diabetes, equivalent to more than one in every 14 individuals. This growing health challenge is driving demand for effective wound management solutions. The market also benefits from heightened awareness of advanced wound care, increased government support, and higher healthcare spending. As a result, there is greater adoption of innovative wound sealant products and technologies aimed at enhancing patient outcomes and lowering overall healthcare costs.
Asia Pacific Wound Sealants Market Trends
The Asia Pacific region is witnessing significant growth in the wound sealants market. This can be attributed to the region's growing diabetes population and rising healthcare expenditure. For instance, the Down to Earth organization estimates that India had 74.2 million diabetics between the ages of 20 and 79 as of December 2021. Furthermore, it is expected that this figure would rise to 124.8 million by 2045. Therefore, an increase in the diabetic population may help the wound sealants market growth in the Asia Pacific region. Furthermore, according to a report published by Insurance Asia, APAC’s healthcare spending is expected to surge 9.9% in 2024. These factors are expected to drive the segment’s growth over the forecast period
China wound sealants market is a key player in the Asia Pacific region, with significant growth anticipated over the forecast period. This expansion is primarily driven by the rising incidence of chronic diseases and a rapidly aging population. According to data from the State Council of the People's Republic of China in October 2024, nearly 297 million people in China were aged 60 or older in 2023, representing 21.1% of the total population. This significant demographic shift is contributing to increased demand for advanced wound care solutions, including wound sealants, to address age-related health issues and chronic wound management, thereby accelerating market growth.
Latin America Wound Sealants Market Trends
The Latin American wound sealants market is experiencing steady growth, driven by several key factors. The aging population across the region, coupled with a growing prevalence of chronic conditions like diabetes and obesity, is leading to a rise in chronic wounds such as diabetic foot ulcers and pressure ulcers. These health challenges drive demand for advanced wound care solutions, including wound sealants. Countries such as Brazil and Argentina are leading this growth trend, supported by their sizeable populations and ongoing improvements in healthcare infrastructure, which are enabling broader access to modern wound management technologies.
Middle East Africa Wound Sealants Market Trends
The growing geriatric population, increasing number of surgeries, and rising incidence of sports-related injuries are expected to propel the Middle East and Africa wound sealants market's growth. In addition, the increasing government initiatives to develop healthcare infrastructure are expected to increase the number of surgeries in the region, leading to an increase in demand for advanced wound sealant products.
Key Wound Sealants Company Insights
The wound sealants market is extremely fragmented, with major and local competitors. Due to the fact that the current market players are stepping up their efforts to grab the majority in the market, fierce competition is anticipated, with the degree of competitiveness perhaps rising even higher. Many market participants are engaging in various strategic activities, such as product launches, mergers and acquisitions, and geographic growth, in an effort to gain a competitive edge over rivals. Thus, with various strategies adopted by the market players, the market is predicted to grow during the forecast period.
Key Wound Sealants Companies
The following key companies have been profiled for this study on the wound sealants market.
-
Terumo Corporation
-
Baxter
-
Advanced Medical Solutions Group plc
-
Johnson & Johnson (Ethicon)
-
BD
-
Integra LifeSciences Corporation
-
Cohera Medical, Inc.
-
LifeBond Ltd.
Competitive Benchmarking
Category
Operating Strategies
Competitive Edge
Weakness
Established Players (Terumo Corporation, Baxter, Johnson & Johnson (Ethicon), BD)
- Expand global market presence through strategic acquisitions, partnerships with hospitals and surgical centers, and investments in clinical studies to improve surgical outcomes and patient safety.
- Enhance manufacturing capabilities and strengthen distribution networks across developed and emerging markets.
- Strong global brand recognition, extensive distribution networks, and long-standing relationships with healthcare providers and surgical facilities.
- Broad product portfolios, strong regulatory expertise, strong clinical evidence, and substantial R&D investments supporting innovation and commercialization of advanced wound sealant technologies.
- High R&D, manufacturing, and regulatory compliance costs associated with advanced surgical sealants and tissue adhesives.
- Exposure to pricing pressures from healthcare reimbursement systems and intense competition from both global and regional wound care manufacturers.
Emerging Players (Advanced Medical Solutions Group plc, Cohera Medical, Inc., LifeBond Ltd)
- Focus on developing specialized biomaterial wound dressings, regenerative wound care products, bioactive matrices, and tissue repair technologies targeting chronic and complex wounds.
- Strengthen collaborations with healthcare institutions, research organizations, and specialty wound care clinics to expand product adoption.
- Strong expertise in niche wound sealant and tissue repair segments, with innovative technologies addressing specific surgical and wound closure needs.
- Greater agility in product development and the ability to target unmet clinical requirements in specialized surgical applications.
- Limited geographic presence and smaller distribution capabilities compared with large multinational medical device companies.
- Higher dependence on a narrower product portfolio and challenges related to scaling operations, securing reimbursement coverage, and obtaining regulatory approvals across multiple regions.
Recent Developments
-
In November 2023, Ethicon, a Johnson & Johnson MedTech company, announced the approval of ETHIZIA, an adjunctive hemostat solution that has been clinically proven to achieve sustained hemostasis in challenging bleeding scenarios.
-
In February 2023, Advanced Medical Solutions Group plc announced the acquisition of Connexicon Medical Limited. Connexicon specializes in tissue adhesive technologies, a strategic addition to bolster AMS’s product portfolio in advanced wound care and surgical adhesives. By integrating Connexicon's tissue adhesive technologies, AMS can expand its portfolio with innovative solutions for wound closure.
Wound Sealants Market Report Scope
Report Attribute
Details
Market size in 2025
USD 584.9 million
Estimated market size in 2026
USD 619.0 million
Projected market size by 2033
USD 880.2 million
Growth rate
CAGR of 5.2% from 2026 to 2033
Base year for estimation
2025
Historical data
2021 - 2024
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million/billion and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Sealants, wound type, end use, distribution channel, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; Norway; Denmark; Sweden; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; Saudi Arabia; South Africa; UAE; Kuwait
Key companies profiled
Terumo Corporation; Baxter; Advanced Medical Solutions Group plc; Johnson & Johnson (Ethicon); BD; Integra LifeSciences Corporation; Cohera Medical, Inc.; LifeBond Ltd.
Customization scope
Free report customization (equivalent up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Wound Sealants Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global wound sealants market report on the basis of sealants, wound type, end use, distribution channel, and region:
-
Sealants Outlook (Revenue, USD Million, 2021 - 2033)
-
Non-Synthetic
-
Collagen Based
-
Synthetic
-
-
Wound Type Outlook (Revenue, USD Million, 2021 - 2033)
-
Acute Wounds
-
Surgical/ Procedure
-
Obstetrics / Gynecology
-
Colorectal
-
Cardiovascular
-
Bariatric and Upper GI
-
Plastic and Reconstructive Surgery
-
Urology
-
Hepato-pancreato-biliary (HPB)
-
Dermatology
-
Others (ENT, Ortho trauma, Neuro, etc.)
-
-
Lacerations & Minor Cuts
-
Burns
-
-
Chronic Wounds
-
Diabetic Foot Ulcers
-
Pressure Ulcers
-
Venous Leg Ulcers
-
Other Chronic Wounds
-
-
-
End Use Outlook (Revenue, USD Million, 2021 - 2033)
-
Acute Care Hospital
-
Ambulatory Surgery Center (ASC)
-
Hospital Outpatient Wound Care Clinic
-
Home Healthcare
-
Skilled Nursing Facility (SNF)
-
Physician Office
-
Burn Center
-
Inpatient Rehabilitation Facility (IRF)
-
Long-term Acute Care Hospital (LTACH)
-
Long-term Care (residential living setting)
-
-
Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
-
Institutional Sales
-
Retail Sales
-
-
Regional Outlook (Revenue, USD Million, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Australia
-
Thailand
-
South Korea
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
Kuwait
-
UAE
-
-
Research Methodology
The wound sealants market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each wound sealants segment quantified using the revenue-capture definitions in the table below.
Segment Definition
Segment - Sealants
Revenue capture definition
Non-Synthetic
Revenue generated from the sale of wound sealants derived from natural or biologically sourced materials used to achieve tissue sealing, wound closure, hemostasis, and leakage prevention. This segment includes fibrin-based, gelatin-based, and albumin-based sealants, as well as other biologically derived wound sealant products used across surgical and wound care applications.
Collagen Based
Revenue generated from the sale of collagen-based wound sealants designed to support tissue adhesion, hemostasis, wound closure, and tissue regeneration. These products utilize collagen derived from animal or other biological sources and are used in surgical procedures and advanced wound management to promote healing and reduce complications.
Synthetic
Revenue generated from the sale of wound sealants manufactured using synthetic polymers and engineered materials. This segment includes polyethylene glycol (PEG)-based sealants, cyanoacrylate adhesives, polyurethane-based sealants, and other synthetic tissue adhesives used for wound closure, bleeding control, and prevention of fluid or leakage across various medical and surgical specialties.
Estimation Model
Methodology
Description
Bottom-Up Epidemiological & Procedure Modeling
Sizing derived from target surgical procedures (CV, ortho, neuro, trauma) across global hospitals multiplied by average wound sealant unit utilization and average selling prices (ASPs).
Top-Down Revenue Triangulation
Tracking OEM corporate biosurgery and advanced surgery revenues (Baxter, Ethicon, BD, Takeda) via annual financial reports, distributor channels, and stripping out adjacent consumables.
Demand-Side Care-Setting Modeling
Analyzing localized clinical consumption volumes across surgical theaters, emergency trauma departments, and ambulatory centers combined with clinical guidelines and hospital purchasing contracts.
Delivered Customizations
This report has been delivered with the following In-depth customizations
Client Request
Customization Delivered
Value Adds
Detailed Competitive Analysis
Deep-dive profiles of top tier-1 market leaders and specialized biotech firms, capturing product portfolios, financial performance, strategic alliances, pipeline assets, and manufacturing capabilities.
Supports rigorous peer benchmarking, highlights whitespace opportunities for differentiation, and identifies potential target candidates for M&A or licensing partnerships.
Disease Epidemiology & Patient Population Analysis
Multi-country epidemiological profiling mapping the annual incidence of high-bleeding risk surgical procedures (Cardiovascular, Spinal, Orthopedic, Hepatic) alongside the prevalence of severe chronic wounds (Stage III/IV Ulcers) requiring advanced structural sealing.
Quantifies the raw total addressable patient volume, establishes clinical necessity baselines for hospital value-analysis committees (VACs), and directly supports targeted geographic product launches.
Region-wise Company Share Analysis
Cross-geographic competitive mapping detailing market share across North America, Europe, Asia-Pacific, Latin America, and MEA, capturing regional preferences and localized domestic manufacturing players.
Supports targeted regional expansion strategies, uncovers localized regulatory or distribution entry barriers, and aligns commercial resources with high-yield geographic zones.
Frequently Asked Questions About This Report
The non-synthetic sealants segment led with a 45.3% revenue share in 2025, while the collagen-based is the fastest-growing segment.
The acute wounds held the largest share of 71.0% in 2025 and is the fastest-growing segment.
The acute care hospital held the largest share of 36.9% in 2025, while home healthcare is the fastest-growing segment.
Institutional sales held the largest share of 81.5% in 2025, while retail sales is the fastest-growing segment.
Key players include Terumo Corporation; Baxter; Advanced Medical Solutions Group plc; Johnson & Johnson (Ethicon); BD; Integra LifeSciences Corporation; Cohera Medical, Inc.; and LifeBond Ltd.
The global wound sealants market size was valued at USD 584.9 million in 2025 and is estimated at USD 619.0 million in 2026.
The global wound sealants market is expected to grow at a CAGR of 5.2% from 2026 to 2033, reaching USD 880.2 million by 2033.
Key factors include the rising global volume of surgical procedures, fueled by an aging population and the increasing prevalence of chronic conditions such as diabetes and cardiovascular diseases.
North America dominated with a 40.3% revenue share in 2024.
Asia Pacific is the fastest-growing region over the forecast period.
About the Author(s)
Medical Devices Research Team
Healthcare · Medical DevicesThis report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.